NOVAVAX, INC. (NVAX) Net margin 2016–2025
NOVAVAX, INC. (NVAX) net profit margin by fiscal year — reported net income divided by reported revenue.
39.2%FY2025 · since FY2016: -1823.5% → 39.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 39.2% | +66.7 pp |
| FY2024 | -27.5% | +27.9 pp |
| FY2023 | -55.4% | -22.2 pp |
| FY2022 | -33.2% | +118.9 pp |
| FY2021 | -152.1% | -64.2 pp |
| FY2020 | -87.9% | +623.1 pp |
| FY2019 | -711.0% | -172.2 pp |
| FY2018 | -538.8% | +50.6 pp |
| FY2017 | -589.5% | +1234.1 pp |
| FY2016 | -1823.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice